Table 1

Comparison of baseline characteristics according to the presence of coronary artery spasm

CharacteristicsTotal
(N=3556)
CAS (+)
(n=830)
CAS (−)
(n=2726)
P value
Age, years54.7±10.354.7±9.354.7±10.60.923
Male, n (%)1958 (55.1)590 (71.1)1368 (50.2)<0.001
Hypertension, n (%)1090 (30.7)256 (30.8)834 (30.6)0.897
Diabetes mellitus, n (%)282 (7.9)70 (8.4)212 (7.8)0.557
Dyslipidaemia, n (%)1113 (31.3)313 (37.7)800 (29.3)<0.001
Smoking, n (%)1201 (33.8)411 (49.5)790 (29.0)<0.001
History of PCI, n (%)74 (2.1)38 (4.6)36 (1.3)<0.001
Clinical presentation, n (%)
 Typical angina153 (4.3)20 (2.4)133 (4.9)
 Atypical angina1475 (41.5)101 (12.2)1374 (50.4)
 Variant angina1507 (42.4)549 (66.1)958 (35.1)
 Acute coronary syndrome350 (9.8)148 (17.8)202 (7.4)
 Aborted sudden cardiac death17 (0.5)3 (0.4)14 (0.5)
 Syncope33 (0.9)7 (0.8)26 (1.0)
Coronary imaging before erg echo, n
 CT CAG/invasive CAG1028/2528122/708906/1820<0.001
 Normal/mild CAD*3327/229715/1152612/114<0.001
Side effects/adverse reactions during erg echo
 Premature termination of erg echo, n (%)20 (0.6)0 (0.0)20 (0.7)
 Systolic blood pressure ≥200 mm Hg, n (%)9 (0.3)18
 Cardiogenic shock, n (%)2 (0.1)11
 Arrhythmias, n (%)
  Atrioventricular block8 (0.2)80
  Sinus bradycardia or pause3 (0.1)30
  Ventricular tachycardia2 (0.1)11
  Atrial fibrillation2 (0.1)02
  Atrial or ventricular premature beat1 (0.0)10
 Myocardial infarction, n000
 Mortality, n000
Medications after erg echo, n (%)
 CCB alone201 (5.7)113 (13.6)88 (3.2)
 CCB+nitrates777 (21.9)637 (76.7)140 (5.1)
 Combination of more than two CCBs89 (2.5)76 (9.2)13 (0.5)
  • Values are mean±SD or n (%).

  • *Mild CAD: CAD with lumen diameter stenosis of <50%.

  • CAD, coronary artery disease; CAG, coronary angiography; CAS, coronary artery spasm; CCB, calcium channel blocker; erg echo, ergonovine echocardiography; PCI, percutaneous coronary intervention.